Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

20%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(3)

Detailed Status

Withdrawn2

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

withdrawn240%

completed240%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completed

Assessment of Reliability of Demirjian Formula for Age Estimation Using Mandibular Third Molar in a Sample of Egyptian Population Using CBT: a Cross-sectional Study

NCT06232135

terminated

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

NCT00658281

Clinical Trials (5)

Showing 5 of 5 trials

NCT06232135

Assessment of Reliability of Demirjian Formula for Age Estimation Using Mandibular Third Molar in a Sample of Egyptian Population Using CBT: a Cross-sectional Study

Completed

NCT03551405

4D Cone Beam CT Reconstruction for Radiotherapy Via Motion Vector Optimization

Terminated

NCT02579187Phase 1

MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial

Withdrawn

NCT01826656Not Applicable

Bone Healing in Healthy and Post-menopausal Osteoporotic Women

Withdrawn

NCT00658281

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 5